Latest Regulatory Delays News

Vault Minerals delivered 78,578 ounces of gold in the March quarter at an AISC of A$3,006/oz, generating a remarkable $229 million in underlying free cash flow. The company completed the first stage of its King of the Hills plant upgrade and declared a maiden dividend, reinforcing its position as a high-yielding gold producer.

Kingfisher Mining has resumed reverse circulation drilling at its Copper Blow project near Broken Hill, targeting extensions of high-grade copper-gold mineralisation to support a maiden resource estimate. The program follows a strategic processing agreement with Broken Hill Mines, underpinning development plans.

Chariot Resources’ planned A$1.425 million strategic investment from Greatpower has lapsed after regulatory hurdles in China stalled approvals. Despite this setback, Chariot continues to engage multiple potential offtake partners for its Nigerian lithium projects, advancing site visits and technical work without firm agreements yet.

St Barbara has completed a major strategic transaction with Lingbao Gold Group, receiving A$389 million in cash and approving a US$333 million investment to expand the New Simberi Gold Project, setting the stage for a significant production boost.

Perpetual Limited has agreed to sell its Wealth Management business to Bain Capital for an upfront $500 million, marking a strategic shift towards asset management and corporate trustee services.

Reef Casino Trust has issued a second supplementary target’s statement as the takeover bid by Iris Cairns Property Pty Ltd extends to August 2026 due to delayed casino licensing approvals. The board maintains its recommendation for unitholders to accept the offer, pending regulatory outcomes and expert advice.

Bio-Gene Technology Limited reports strong progress in toxicology studies for Flavocide, targeting its first regulatory submission in Australia by March 2027. This milestone sets the stage for global registrations of the novel insecticide with a new mode of action.

Orezone Gold Corporation reported a robust 33% increase in revenue for FY2025, underpinned by higher gold prices and the start of hard rock production at Bomboré. The company also announced a strategic acquisition of the Casa Berardi gold mine in Canada.

Platformo Ltd reported a modest 5% revenue increase in 2025 driven by its Malaysian subsidiary Biztrak, but faced a higher net loss due to regulatory delays and increased corporate advisory costs.

Cyclopharm Limited reported a 17% revenue increase to a record $32.3 million in 2025, powered by a 226% surge in US Technegas sales. The company is accelerating its US rollout with plans for up to 300 installations in 2026, while advancing clinical trials beyond pulmonary embolism.

Caravel Minerals confirms its Definitive Feasibility Study for the Caravel Copper Project remains on track for mid-2026, while regulatory water investigations push the Final Investment Decision to late 2027. Meanwhile, strategic talks with Adani advance steadily.

Riversgold Limited has resolved all objections to its Mining Lease application for the Northern Zone Gold Project near Kalgoorlie, paving the way for imminent lease approval and advancing its partnership with MEGA Resources.